🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the side effects of fludarabine phosphate, cy...
Status
Terminated
Location
The Children's Hospital at TriStar Centennial
Start Date
2006-05-24
Trial ID
NCT00358657
A new immunosuppressive drug, based on the inhibition of an important enzym...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-08
Trial ID
NCT00483756
Treatments Being Tested
Clinical trial for the novo transplant recipients, which aims to assess tol...
Status
Completed
Location
Novartis
Start Date
2005-02
Trial ID
NCT00238953
Treatments Being Tested
This is a continuation of a pilot study which is now regarded as a phase II...
Status
Completed
Location
University of Nebraska Medical Center, Section of Oncology/Hematology
Start Date
2000-12-08
Trial ID
NCT00571662
Treatments Being Tested
This is a single-center, single-arm Phase Investigational Intervention Tria...
Status
Recruiting
Location
Shanghai Changzheng Hospital
Start Date
2021-09-14
Trial ID
NCT06196996
Demyelinating Diseases of the Central Nervous System Registry for Patients ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-06-20
Trial ID
NCT05415579
Treatments Being Tested
Idiopathic nephrotic syndrome is steroid-sensitive in more than 90% of case...
Status
Completed
Location
Robert Debre Hospital, AP-HP
Start Date
2010-09
Trial ID
NCT01092962
Treatments Being Tested
The objectives of this prospective non-interventional study are to characte...
Status
Recruiting
Location
Cahaba Dermatology & Skin Health Center- Site Number : 8400006
Start Date
2025-11-17
Trial ID
NCT07290803
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241
The purpose of this study is to determine whether Infliximab (monoclonal an...
Status
Completed
Location
University Hospitals Birmingham NHS Foundation Trust
Start Date
2003-01
Trial ID
NCT00753103